Ambalal Sarabhai Enterprises Ltd.

₹28.41

+ 1.39 (5.14%)

04:01 pm - close price

BSE: AMBALALSA

NSE: AMBASARABH

Industry: Pharmaceuticals & Drugs

House: Sarabhai

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 0.64Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.64Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 5.20Good: 20

❌

Current Ratio

Bad: 1Current: 0.98Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 3.57Good: 15

❌

Debt to Total Assets

Bad: 1Current: 18.11Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.64Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.64Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 5.20Good: 20

❌

Current Ratio

Bad: 1Current: 0.98Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 3.57Good: 15

❌

Debt to Total Assets

Bad: 1Current: 18.11Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	36.10	40.01	43.11	54.35	40.70
Expenditure+	39.09	38.96	40.58	48.62	39.86
Other Income+	1.37	2.85	1.36	4.79	2.30
Operating Profit	-2.99	1.05	2.53	5.73	0.84
Interest	0.95	0.92	0.99	0.90	0.95
Depreciation and Amortization	1.05	1.14	1.13	0.25	0.98
Profit Before Tax	-4.60	1.81	1.88	8.29	0.84
Tax+	0.27	0.72	0.70	-0.73	0.50
Net Profit	-4.87	1.08	1.18	9.02	0.35

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	16364.31	19674.51	17028.40	17357.05	19618.53
Operational Expenses+	16518.41	17151.46	16144.30	16491.91	18757.97
Operating Profit	-154.10	2523.05	884.10	865.14	860.56
Other Income	3057.94	4201.56	1248.88	1037.47	1138.49
OPM %	-0.94	12.82	5.19	4.98	4.39
Depreciation and Amortisation	241.15	231.85	275.51	357.47	400.66
Interest	319.82	204.16	270.86	608.89	478.96
Profit Before Tax	3254.07	5419.35	1517.21	665.10	483.36
Tax	318.72	722.33	380.80	320.50	40.71
Net Profit	2935.52	4721.85	1144.74	568.07	493.11

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	20777.70	23005.03	24574.34	24952.48	26823.45
Liabilities+	20777.70	23005.03	24574.34	24952.48	26823.45

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-229.89	1147.21	572.45	888.73	-1761.52
Cash from Investing Activity	1008.98	507.68	-1678.18	-529.56	1326.12
Cash from Financing Activity	-584.01	-1918.57	908.54	-294.54	-152.75
Net Cash Flow	195.08	-263.68	-197.19	64.63	-588.15
Opening Cash & Cash Equivalents	1278.77	1473.85	1210.17	1012.98	1077.61
Closing Cash & Cash Equivalents	1473.85	1210.17	1012.98	1077.61	489.46

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	31.36	31.35	31.35	31.35	31.35	31.35	30.77	30.77	30.77	30.77
Public+	68.64	68.65	68.65	68.65	68.65	68.65	69.23	69.23	69.23	69.23
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	168396	170015	169630	170912	171221	172338	169228	170079	171944	175222

Corporate Actions

65 events in the last 3 years

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	36.10	40.01	43.11	54.35	40.70
Expenditure+	39.09	38.96	40.58	48.62	39.86
Other Income+	1.37	2.85	1.36	4.79	2.30
Operating Profit	-2.99	1.05	2.53	5.73	0.84
Interest	0.95	0.92	0.99	0.90	0.95
Depreciation and Amortization	1.05	1.14	1.13	0.25	0.98
Profit Before Tax	-4.60	1.81	1.88	8.29	0.84
Tax+	0.27	0.72	0.70	-0.73	0.50
Net Profit	-4.87	1.08	1.18	9.02	0.35

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	16364.31	19674.51	17028.40	17357.05	19618.53
Operational Expenses+	16518.41	17151.46	16144.30	16491.91	18757.97
Operating Profit	-154.10	2523.05	884.10	865.14	860.56
Other Income	3057.94	4201.56	1248.88	1037.47	1138.49
OPM %	-0.94	12.82	5.19	4.98	4.39
Depreciation and Amortisation	241.15	231.85	275.51	357.47	400.66
Interest	319.82	204.16	270.86	608.89	478.96
Profit Before Tax	3254.07	5419.35	1517.21	665.10	483.36
Tax	318.72	722.33	380.80	320.50	40.71
Net Profit	2935.52	4721.85	1144.74	568.07	493.11

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	31.36	31.35	31.35	31.35	31.35	31.35	30.77	30.77	30.77	30.77
Public+	68.64	68.65	68.65	68.65	68.65	68.65	69.23	69.23	69.23	69.23
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	168396	170015	169630	170912	171221	172338	169228	170079	171944	175222

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-229.89	1147.21	572.45	888.73	-1761.52
Cash from Investing Activity	1008.98	507.68	-1678.18	-529.56	1326.12
Cash from Financing Activity	-584.01	-1918.57	908.54	-294.54	-152.75
Net Cash Flow	195.08	-263.68	-197.19	64.63	-588.15
Opening Cash & Cash Equivalents	1278.77	1473.85	1210.17	1012.98	1077.61
Closing Cash & Cash Equivalents	1473.85	1210.17	1012.98	1077.61	489.46

Ratios

Reported EPS

Bad: 2Current: 0.64Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.64Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 5.20Good: 20

❌

Current Ratio

Bad: 1Current: 0.98Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 3.57Good: 15

❌

Debt to Total Assets

Bad: 1Current: 18.11Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.64Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.64Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 5.20Good: 20

❌

Current Ratio

Bad: 1Current: 0.98Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 3.57Good: 15

❌

Debt to Total Assets

Bad: 1Current: 18.11Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	20777.70	23005.03	24574.34	24952.48	26823.45
Liabilities+	20777.70	23005.03	24574.34	24952.48	26823.45

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Ambalal Sarabhai Enterprises Ltd.

₹28.41

+ 1.39 (5.14%)

04:01 pm - close price

BSE: AMBALALSA

NSE: AMBASARABH

Industry: Pharmaceuticals & Drugs

House: Sarabhai

Overview

Corporate Actions

65 events in the last 3 years